F-group (family)
7573.1.1.1 Pribosyltran
Ligands and drugs
2,861
Member domains
665
with ligand contacts (≤ 4 Å)
23.2% of members
617
with DrugDomain annotations
21.6% of members
413
with a DrugBank compound
14.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7573.1.1.1 belongs to X-group 7573 PRTase-like, which binds 6.3 ligand superclasses per 20 proteins, narrower than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 57 |
| DB01632 | PRP | 5-O-phosphono-alpha-D-ribofuranosyl diphosphate | 49 |
| DB00131 | AMP | Adenosine phosphate | 28 |
| DB04566 | IMP | Inosinic Acid | 28 |
| DB00173 | ADE | Adenine | 25 |
| DB04022 | G4P | Guanosine tetraphosphate | 17 |
| DB00437 | 7HP | 7-HYDROXY-PYRAZOLO[4,3-D]PYRIMIDINE | 12 |
| DB03942 | PCP | Carboxylic PRPP | 12 |
| DB02309 | XMP | 5-monophosphate-9-beta-D-ribofuranosyl xanthine | 11 |
| DB16833 | ADP | Adenosine disphosphate | 10 |
| DB02262 | ORO | Orotic acid | 9 |
| DB04076 | HPA | Hypoxanthine | 8 |
| DB11326 | BO3 | Boric acid | 8 |
| DB02957 | OMP | Orotidylic acid | 7 |
| DB02075 | IRP | [(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate | 6 |
| DB04160 | PPV | Pyrophosphoric acid | 6 |
| DB04356 | 9DG | 9-Deazaguanine | 5 |
| DB02053 | R5P | Ribose-5-phosphate | 4 |
| DB02134 | XAN | Xanthine | 4 |
| DB03345 | BME | Mercaptoethanol | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 275 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 61 |
| PRP | 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose | 49 |
| CL | CHLORIDE ION | 41 |
| POP | PYROPHOSPHATE 2- | 36 |
| NAmetal | SODIUM ION | 32 |
| AMP | ADENOSINE MONOPHOSPHATE | 29 |
| IMP | INOSINIC ACID | 28 |
| ADE | ADENINE | 25 |
| YPG | [3-[(3~{R},4~{R})-3-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-[(2~{S})-2-oxidanyl-2-phosphono-ethoxy]pyrrolidin-1-yl]-3-oxidanylidene-propyl]phosphonic acid | 20 |
| G4P | GUANOSINE-5',3'-TETRAPHOSPHATE | 19 |
| 3L4 | [(2-{[2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)ethyl][(E)-2-phosphonoethenyl]amino}ethoxy)methyl]phosphonic acid | 14 |
| 45T | {[(2S)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)propane-1,2-diyl]bis(oxyethane-2,1-diyl)}bis(phosphonic acid) | 12 |
| 7HP | 7-HYDROXY-PYRAZOLO[4,3-D]PYRIMIDINE | 12 |
| 8QI | ({(2S)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2S)-2-hydroxy-2-phosphonoethoxy]propoxy}methyl)phosphonic acid | 12 |
| PCP | 1-ALPHA-PYROPHOSPHORYL-2-ALPHA,3-ALPHA-DIHYDROXY-4-BETA-CYCLOPENTANE-METHANOL-5-PHOSPHATE | 11 |
| 3L5 | (2-{[2-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)ethyl][2-(2-phosphonoethoxy)ethyl]amino}ethyl)phosphonic acid | 10 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 10 |
| SF4 | IRON/SULFUR CLUSTER | 10 |
| XMP | XANTHOSINE-5'-MONOPHOSPHATE | 10 |